Relapsed or Refractory EBV-associated Hematological Malignancies
1 clinical trials · Condition
◉ Watch Relapsed or Refractory EBV-associated Hematological Malignancies
| Record | Firm | Date |
|---|---|---|
| A Phase I Clinical Study of KSD-101 in Patients With Relapsed or Refractory EBV-associated Hematological Malignancies (NCT07532746) | Kousai Bio Co., Ltd. | 2026-05-01 |
Track Relapsed or Refractory EBV-associated Hematological Malignancies automatically
Every clearance here is in the API, with alerts when new ones post.